Fabino Enterprises 2026 filings: results and stock at ₹20
Fabino Enterprises Ltd
FABINO
Ask Iris
Stock snapshot and why the filings matter
Fabino Enterprises’ stock price was reported at ₹20.31 as of 23 Aug, 2026. The company is listed in India and the filing details reference BSE.NS with security code 543444. A cluster of exchange disclosures around board meetings and periodic financial results provides a clear paper trail of what the board considered, approved, and communicated under SEBI LODR requirements. These filings matter because they are the primary source for audited and unaudited financial outcomes and board-level decisions. They also offer context on corporate actions such as dividend recommendations and reserve transfers. For smaller listed companies, board-meeting outcomes often contain the most direct signals of performance changes and governance updates.
May 23, 2026: Board approves audited FY26 results
A key disclosure is dated 2026-05-23 and is described as an “Earnings Release” linked to results for the financial year ended March 31, 2026. The filing is characterised as an official outcome-of-board-meeting document under SEBI LODR regulations. It announces the approval of audited standalone and consolidated half-year and full-year financial results, along with the independent auditor’s report. The document is described as not being the full annual report, but an initial announcement of periodic financial results. Alongside this, the material also references the audited standalone and consolidated financial results with supporting statements such as assets and liabilities and cash flow statement for the half year and year ended March 31, 2026.
What the May 20, 2026 notice signalled
Ahead of the audited outcome, a separate exchange communication dated 2026-05-20 is described as a regulatory filing under SEBI LODR Regulation 29(1). This notice informed BSE that a board meeting was scheduled for 23/05/2026. The stated agenda was to consider and approve the company’s half-yearly and annual audited financial results. The description emphasises that this notice did not carry financial numbers and was primarily a regulatory intimation of the scheduled meeting. Together, the May 20 notice and the May 23 outcome form a typical disclosure sequence: meeting intimation followed by results approval and submission.
Prior period: H1 FY26 loss reported for Sep 30, 2025
The provided information also includes a summary of unaudited results for the half year ended September 30, 2025. Fabino Enterprises Limited reported a standalone loss of ₹24.87 lakh and a consolidated loss of ₹18.50 lakh for that half year. This was compared with profits of ₹25.93 lakh (standalone) and ₹18.80 lakh (consolidated) in the previous year’s comparable period. The board approved these unaudited financial results at its meeting on November 13, 2025. The summary attributes the weaker profitability to reduced revenue from operations and increased expenses impacting profitability. While the underlying line items are not provided in the text, the direction of change is clearly stated through the shift from profit to loss.
November 13, 2025: Board meeting for unaudited results
A corporate-actions table references an announcement dated 13 Nov 2025 for “board-meetings” with the purpose noted as “Half Yearly Results.” Separately, the narrative states that the board meeting on November 13, 2025 discussed and approved unaudited standalone and consolidated financial results. This aligns with the broader pattern of periodic reporting through board approvals and exchange submissions. The company is also referenced as formerly being known as Fabino Life Sciences Ltd., indicating a legacy name used in some communications.
Dividend stance and reserves: conservation of resources
The text includes a specific statement that the board decided not to transfer any amount to the Reserves for the year under review. It also states that, considering the company’s growth and the need to conserve resources, the directors did not recommend any dividend for the year ended March 31, 2025. These are governance and capital allocation signals that are typically watched by investors, especially when profitability is under pressure. However, the information provided is limited to the stated decisions, without additional cash-flow or balance-sheet context.
Board and compliance changes reported in 2025
Multiple board outcomes and notices indicate changes in key managerial positions during 2025. The board appointed Mrs. Vandana Jain as Additional Executive Director on August 28, 2025, subject to shareholder approval at the upcoming general meeting. At the same time, the board accepted the resignation of Mr. Nitin Mehra as Additional Executive Director due to personal reasons. Another board outcome notes the appointment of CS Anand Katarmal as Company Secretary and Compliance Officer with effect from June 20, 2025. There is also a reference indicating Kanchi Gehlot as Company Secretary and Compliance Officer with effect from May 29, 2025, as per a BSE announcement dated 29/05/2025.
Earlier board meeting notices and audit-related agenda items
The content also references a board meeting scheduled on 29/05/2025 to consider and approve audited financial results (standalone and consolidated) for the half year and year ended March 31, 2025. The same agenda includes appointment of M/s JNG & Co. LLP (Firm Registration Number L2024MH017500) as the secretarial auditor for FY 2025-26 and 2026-27, along with other appointment-related items indicated in truncated form. In addition, a March 17, 2025 board meeting outcome notes appointment of Mr. Nitin Mehra as Additional Executive Director (subject to shareholder approval) and acceptance of resignation of Mr. Jitender Kumar. These items show a mix of routine financial approvals and governance actions being routed through board and exchange processes.
Key facts from the disclosures
Conclusion
The filings summarised here place Fabino Enterprises’ key disclosures around audited FY26 approvals and earlier unaudited H1 FY26 numbers in a single timeline. They also document board-level governance actions, including director changes and appointments of compliance officers and auditors. The most concrete performance datapoint provided is the swing to loss in the half year ended September 30, 2025 versus profit in the prior-year period. Future updates, where applicable, would come through subsequent board-meeting outcomes, shareholder approvals referenced in the appointments, and periodic results filings on the exchanges.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
